Search the Newsreel

Arvinas (ARVN) holder Noah C. Berkowitz plans sale of 30,000 shares

Noah C. Berkowitz, a shareholder of Arvinas (ARVN), has filed notice to sell 30,000 shares of common stock for an approximate aggregate price of $264,000 through Morgan Stanley. The filing also disclosed a previous sale of 24,000 shares on July 9, 2026, for $201,528. …

Arvinas (NASDAQ: ARVN) posts $169.4M profit on VEPPANU and Rigel deals

Arvinas (NASDAQ: ARVN) reported a significant financial turnaround in Q2 2026, posting a net income of $169.4 million and revenue of $249.7 million, compared to a net loss of $61.2 million and $22.4 million revenue in Q2 2025. This profitability was largely driven by …

Arvinas, Inc. Stock 12‑Month Price Target Cut to $14.85, Implies 84% Upside

Arvinas, Inc.'s average 12-month price target has been lowered from $15.08 to $14.85 by 13 analysts, with individual forecasts ranging from $6 to $24. This updated target suggests an 84% potential upside based on the Aug. 3 closing price. Despite the price target cut, …

ARVINAS, INC. 2026: Revenue $249.7M, EPS $2.58— 10-Q Summary

ARVINAS, INC. reported significant financial growth in 2026, with revenue reaching $249.7M and diluted EPS at $2.58, largely driven by licensing and milestone recognition. Key business highlights include FDA approval for VEPPANU and its out-license to Rigel, leading to substantial upfront and milestone payments. …

Zenas BioPharma (ZBIO) Projected to Release Quarterly Earnings on Tuesday

Zenas BioPharma (ZBIO) is expected to announce its Q2 2026 earnings before market open on Tuesday, August 11th. Analysts forecast a loss of $1.12 per share on $15 million in revenue, following a Q1 loss of $1.46 per share which slightly beat estimates. The …

Renasant Corp (RNST) Director Edward Mcgraw Sells 35,000 Shares

Renasant Corp (RNST) Director Edward Mcgraw sold 35,000 shares of the company on August 3, 2026, for approximately $1.54 million, bringing his total ownership to 211,458 shares. This sale contributes to a broader trend of more insider selling than buying at Renasant Corp over …

BVN Crosses Above Key Moving Average Level

In trading on Tuesday, shares of Compania de Minas Buenaventura S.A. (Symbol: BVN) crossed above their 200 day moving average of $31.76, changing hands as high as $32.21 per share. Compania de Minas Buenaventura S.A. shares are currently trading up about 5.7% on the …

Price to earnings forward of PanAsialum Holdings Co. Ltd. – HKEX:2078

BTIG reiterates Arvinas stock Buy rating on pipeline execution

BTIG reiterated a Buy rating and an $18.00 price target on Arvinas Inc. (NASDAQ:ARVN) following the company's strong second-quarter earnings report. Arvinas reported significant GAAP revenue of $249.7 million and a cash position of $567.9 million, providing runway into the second half of 2028. …

Arvinas expects cash runway into the second half of 2028 as ARV-102 PSP trials shift to 2027

Earnings Call Insights: Arvinas (ARVN) Q2 2026 MANAGEMENT VIEW * “We’ve reached 3 significant strategic milestones since the start of the year, beginning with the first-ever FDA approval of a PROTAC degrader, VEPPANU,” said CEO Randy Teel. He added, “we completed an out-licensing of …

San Gabriel: Buenaventura comenzó a registrar volúmenes de ventas en el segundo trimestre

Compañía de Minas Buenaventura's San Gabriel mine in Moquegua began registering sales volumes in Q2 2026, despite ramp-up challenges with tailings management. The mine reported an initial gold sales cost (CAS) of US$5,640/oz, which is not yet representative of long-term costs due to current …

Leonardo DRS (NASDAQ: DRS) holder details planned and recent share sales

Jason Rinsky, a shareholder of Leonardo DRS (DRS), has filed to sell 3,864 shares of common stock through Fidelity Brokerage Services LLC on August 4, 2026. These shares originated from restricted stock vesting on March 15, 2025, as compensation. The filing also reveals two …

Wedbush Adjusts Price Target on Arvinas to $12 From $11, Maintains Neutral Rating

Wedbush has increased its price target for Arvinas (ARVN) to $12 from $11, while maintaining a Neutral rating on the stock. This adjustment comes as Arvinas continues to advance its PROTAC protein degrader platform and multiple investigational drugs through clinical development.

Arvinas (NASDAQ:ARVN) Trading 14.8% Higher Following Better-Than-Expected Earnings

Arvinas (NASDAQ:ARVN) saw its shares surge 14.8% after reporting better-than-expected quarterly earnings and revenue. The company beat consensus EPS estimates by $2.95 and reported a 1,014.7% year-over-year revenue increase. Despite mixed analyst ratings, the stock holds a consensus Hold rating with a target price …

Arvinas (NASDAQ:ARVN) Releases Earnings Results, Beats Expectations By $2.95 EPS

Arvinas Inc (ARVN) is preparing to release its Q2 2026 earnings on August 4, 2026, with analysts forecasting $32.54 million in revenue and an EPS of -$0.44. Despite missing previous quarter's estimates, the GF Value suggests a 34.37% upside from its current price, and …

Transcript: Arvinas Q2 2026 Earnings Conference Call

Arvinas (NASDAQ: ARVN) reported its Q2 2026 earnings, highlighting significant strategic milestones including FDA approval of their first PROTAC degrader, Vepanu, and an out-licensing deal with Rigel Pharmaceuticals. The company announced $249.7 million in revenue for the quarter and a strong cash position of …

Arvinas reports $249.7M Q2 revenue, $169.4M net income and guidance into H2 2028

Arvinas reported strong financial results for Q2 2026, with revenue of $249.7 million and net income of $169.4 million, largely due to collaboration and licensing agreements. The company announced that its cash reserves of $567.9 million are sufficient to fund operations into the second …

Gráfico Cia Energetica Minas Gerais Cemig (CMIG4)

This page displays the live stock chart for Cia Energetica Minas Gerais Cemig (CMIG4) on the BOV exchange. It provides current stock data, including the latest price, daily change, and closing time. The page also offers various tools and information related to CMIG4, such …

D-Wave and Nasdaq Verafin Partner to Develop Quantum Applications for Financial Crime Detection

D-Wave Quantum Inc. has partnered with Nasdaq Verafin to explore the use of quantum-hybrid computing for financial crime detection. This collaboration will leverage D-Wave's quantum annealing systems and hybrid machine learning to enhance anti-money laundering, fraud detection, and scam prevention. A proof-of-concept project will …

Levi & Korsinsky Urges Zenas BioPharma, Inc. (ZBIO) Shareholders to Act Before Lead Plaintiff Deadline June 16, 2025

Levi & Korsinsky is urging shareholders of Zenas BioPharma, Inc. (ZBIO) to act before the lead plaintiff deadline of June 16, 2025, in a lawsuit alleging that the company made false statements regarding its financial runway following its September 2024 IPO. The lawsuit claims …

The Top 5 Analyst Questions From Renasant’s Q2 Earnings Call

Arvinas Q2 Earnings Call Highlights

ARVINAS ($ARVN) Releases Q2 2026 Earnings

Arvinas Inc (ARVN) is preparing to release its Q2 2026 earnings on August 4, 2026, with analysts forecasting $32.54 million in revenue and an EPS of -$0.44. Despite missing previous quarter's estimates, the GF Value suggests a 34.37% upside from its current price, and …

Arvinas earnings beat by $2.96, revenue topped estimates

Class Action Filed Against Zenas BioPharma, Inc. (ZBIO) Over Securities Violations - Contact Levi & Korsinsky Today

Levi & Korsinsky, LLP has filed a class action lawsuit against Zenas BioPharma, Inc. (ZBIO) on behalf of investors who purchased securities during its September 2024 IPO. The lawsuit alleges that Zenas BioPharma materially overstated its ability to fund operations with existing cash and …

D-Wave Quantum Stock Surges on Nasdaq Verafin Deal

D-Wave Quantum Inc. (NASDAQ: QBTS) shares are surging after announcing a collaboration with Nasdaq Verafin to apply quantum technology in the fight against financial crime. The initiative will initially focus on a proof-of-concept to determine if D-Wave's annealing quantum systems can identify complex patterns …

Naas Petrol Factory Co. Signs Lease Agreement with Saudi Authority for Industrial Cities and Technology Zones to Establish Petrochemical Manufacturing Plant in Al Kharj Industrial City

Renasant Corporation stock hits 52-week high at 44.52 USD

Renasant Corporation (RNST) stock has reached a new 52-week high of $44.52, reflecting a 22.16% increase over the last year. The regional bank, with a market capitalization of $4.1 billion, trades at a P/E ratio of 13.34 and is considered undervalued by InvestingPro. Despite …

How Stronger First-Half 2026 Profitability Will Impact Compañía de Minas Buenaventura (BVN) Investors

Nasdaq gives The GrowHub Limited (Nasdaq: TGHL) more time on merger plan

The GrowHub Limited (Nasdaq: TGHL) has received a conditional extension from Nasdaq until December 2, 2026, to regain compliance with listing standards, including the minimum bid price and stockholders' equity requirements. This extension is crucial as TGHL pursues a strategic merger with EnChem Co., …

NusaTrip Incorporated Notified of Anticipated Delisting from The Nasdaq Stock Market

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified NusaTrip Incorporated (Nasdaq: NUTR) that its securities will be delisted from the Nasdaq Stock Market LLC on August 12, 2026, unless the company appeals …

Magnitude International Ltd. Notified of Anticipated Delisting from The Nasdaq Stock Market

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Magnitude International Ltd. (Nasdaq: MAGH) that its securities will be delisted from the Nasdaq Stock Market LLC on August 12, 2026, unless the company …

Nasdaq to Delist Magnitude International Ltd. Securities on August 12 Unless Company Appeals

Nasdaq announced that Magnitude International Ltd. will be delisted on August 12, 2026, unless the company appeals the decision. Trading of Magnitude's securities has been halted since December 19, 2025, following a temporary suspension by the U.S. Securities and Exchange Commission. If delisted, the …

Arvinas Q2 2026 Earnings Preview

* Arvinas (ARVN [https://seekingalpha.com/symbol/ARVN]) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before market open. * The consensus EPS Estimate is -$0.28 [https://seekingalpha.com/symbol/ARVN/earnings/estimates] and the consensus Revenue Estimate is $60.69M (+170.9% Y/Y). * Over the last 3 months, EPS estimates have …

Renasant Corp (RNST) director sells 35,000 shares in insider trade

Renasant Corp director Edward Robinson McGraw sold 35,000 shares of common stock on August 3, 2026, at $43.88 per share, totaling $1.54 million. Following this transaction, McGraw directly owns 211,458 shares of Renasant Corp common stock. The sale was an open-market transaction and was …

Update: D-Wave Quantum Shares Rise After Signing Deal With Nasdaq Verafin to Improve Financial Crime Detection

(Updates with D-Wave Quantum's latest stock move in the headline and in the first paragraph.) D-W PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …